Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Profound Medical Corp PROF


Primary Symbol: T.PRN

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure... see more

TSX:PRN - Post Discussion

Profound Medical Corp > Good week so far, hopefully earnings will help
View:
Post by homer111 on Nov 07, 2024 12:46pm

Good week so far, hopefully earnings will help

PRN is up about 20% for the week - let's hope earnings this afternoon will help continue this trend. Should be a decent 2025 as well!
Comment by HomerAndCompany on Nov 14, 2024 9:17am
Revenue was up two thirds over the same quarter in 2023, despite some patients presumably putting treatment off until the CPT codes come into effect in January, 2025. I thought that was a decent performance. But we couldn`t maintain the share price boost that the good CPT code news provided. I didn`t notice anything negative in the Q3 report other than the fact that the target of 75 treatment ...more  
Comment by homer111 on Nov 22, 2024 10:58am
from one homer to another - i hope you're right! it seems to me like 2025 should be a banner year for PRN with reimbursements coming into effect. anyone else loading up also in anticipation of much larger revenue growth next year? 
Comment by HomerAndCompany on Nov 23, 2024 3:40pm
Another way to look at the number of sites is that if the existing sites were just moderately busy, like an average of 1 treatment per week per site, Profound would be very near to the break even point. If the existing sites were anything remotely like "too busy" Profound would be making a very healthy profit. So if not hitting their target of 75 sites in 2024 becomes a "problem ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities